Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N C Barnes

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 1, 1995
PAF and asthma--time for an appraisal?L Kuitert, N C Barnes
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 5, 2001
What are the alternatives to increasing inhaled corticosteroids for the long term control of asthma?P Flood-Page, N C Barnes
Pulmonary Pharmacology|March 1, 1993
Inhibition of leukotriene synthesis: new therapy in asthma?K P Hui, N C Barnes
Thorax|December 1, 1996
Leukotriene B4 and asthmaP E Christie, N C Barnes
The British Journal of Clinical Practice|September 1, 1995
Drugs affecting the leukotriene pathway in asthmaN C Barnes, L M Kuitert
Lancet (London, England)|May 4, 1991
Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonistK P Hui, N C Barnes
Thorax|March 18, 2000
Leukotriene receptor antagonists: useful in acute asthma?L M Kuitert, N C Barnes
Postgraduate Medicine|October 1, 1984
Mast-cell-derived mediators in asthma. Arachidonic acid metabolitesN C Barnes, J F Costello
International Journal of Clinical Practice|August 24, 2005
Unscheduled healthcare resource use among asthma patients receiving low-dose inhaled corticosteroids maintenance treatmentN C Barnes, A E Williams
Clinical Reviews in Allergy & Immunology|August 7, 1999
Biochemistry and physiology of the leukotrienesN C Barnes, L J Smith
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 1, 1995
PAF and asthma--time for an appraisal?L Kuitert, N C Barnes
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 5, 2001
What are the alternatives to increasing inhaled corticosteroids for the long term control of asthma?P Flood-Page, N C Barnes
Pulmonary Pharmacology|March 1, 1993
Inhibition of leukotriene synthesis: new therapy in asthma?K P Hui, N C Barnes
Thorax|December 1, 1996
Leukotriene B4 and asthmaP E Christie, N C Barnes
The British Journal of Clinical Practice|September 1, 1995
Drugs affecting the leukotriene pathway in asthmaN C Barnes, L M Kuitert
Lancet (London, England)|May 4, 1991
Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonistK P Hui, N C Barnes
Thorax|March 18, 2000
Leukotriene receptor antagonists: useful in acute asthma?L M Kuitert, N C Barnes
Postgraduate Medicine|October 1, 1984
Mast-cell-derived mediators in asthma. Arachidonic acid metabolitesN C Barnes, J F Costello
International Journal of Clinical Practice|August 24, 2005
Unscheduled healthcare resource use among asthma patients receiving low-dose inhaled corticosteroids maintenance treatmentN C Barnes, A E Williams
Clinical Reviews in Allergy & Immunology|August 7, 1999
Biochemistry and physiology of the leukotrienesN C Barnes, L J Smith
Pageof 10